Loading...

BioMarin Pharmaceutical Inc.

BMRN•NASDAQ
Healthcare
Biotechnology
$53.24
$-2.22(-4.00%)
U.S. Market opens in 12h 16m

BioMarin Pharmaceutical Inc. (BMRN) Stock Overview

Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap10.2B
P/E Ratio38.15
EPS (TTM)$1.39
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$50.91
3 Months$59.58
1 Year Target$39.73

BMRN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMarin Pharmaceutical Inc. (BMRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.15 and a market capitalization of 10.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.00%
5-Day Change
-1.43%
1-Month Change
-5.28%
3-Month Change
-6.84%
6-Month Change
0.83%
Year-to-Date (YTD) Change
-10.42%
1-Year Change
-14.21%
3-Year Change
-44.90%
5-Year Change
-31.46%
All-Time (Max) Change
305.48%

Contact Information

https://www.biomarin.com
415 506 6700
770 Lindaro Street, San Rafael, CA, 94901

Company Facts

3,040 Employees
IPO DateJul 26, 1999
CountryUS
Actively Trading

Frequently Asked Questions